All lobbying filings

INFUSION PROVIDERS ALLIANCE

Lobbying for INFUSION PROVIDERS ALLIANCE

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 1

HR 879
Medicare Patient Access and Practice Stabilization Act of 2025

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.

Health Issues

Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.